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NEURAMINIC ACID: THE FUNCTIONAL GROUP OF SOME
BIOLOGICALLY ACTIVE MUCOPROTEINS
Present knowledge would attribute to proteins a wider range of biological
activity than is possessed by any other group of natural substances. Thus
enzymes, respiratory pigments, antibodies, many antigens, and several hor-
mones are protein in nature. Sometimes the biologically active substance is
a simple protein, consisting of amino acid residues only (papain, carboxy-
peptidase, lysozyme, insulin, glucagon, ,8-corticotropin, etc.). In other cases
the protein is conjugated with nonprotein material as in the photosynthetic
pigments, respiratory enzymes, the oxygen carriers haemoglobin and chloro-
cruorin, the gonadotropic hormones, Castle's intrinsic factor, blood group
substances, virus haemagglutinin inhibitors, and others. Whereas it is well
established that the haem iron in haematoproteins provides the active centre,
and that flavin adenine mononucleotide and dinucleotide, respectively, are
the functional groups of catalytically active flavoproteins, the literature pro-
vides little, if any, information about the structural element responsible for
the biological activity of mucoproteins, i.e., carbohydrate-protein complexes
with high protein content.
Over the past nine years the staff of this Institute has been engaged in
an investigation of the interaction between the influenza virus particle and
some mucoproteins at both the biological and the biochemical levels. These
investigations, together with those from other laboratories, resulted in a
definition of the biological activity of the mucoproteins concerned in the
isolation of the functional component and in the elucidation of its chemical
structure.
The various observations, in their chronological order, leading to the
information that certain mucoproteins display biological activity when influ-
enza virus is used as indicator system, have been described in detail in a
previous paper15 in this Journal. The results up to that time and their
interpretation may be summarized as follows:
1. Mucoproteins prepared from human urine (UM) and from bovine
submaxillary glands (BSM) in an electrophoretically homogeneous state
inhibit in high dilution haemagglutination by appropriately heat-treated
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virus particles (indicator virus) of certain strains. This holds also for the
mucoprotein fraction ovomucin prepared from egg-white.6
2. When pretreated with living influenza virus or with a purified soluble
enzyme (RDE) from vibrio cholerae, these mucoproteins lose irreversibly
the ability to inhibit virus haemagglutination.5
3. Concomitant with the loss of biological activity, a small molecular
weight compound is released from the mucoprotein upon virus or RDE
action.'
These observations indicated the operation of attractive forces between
heated virus and the soluble mucoprotein resulting in adsorption of the
virus particle to the fibrous mucoprotein and thus preventing haemagglu-
tination. A further inference from the findings was the presence of an en-
zymatically active grouping at two or more sites of the virus surface attack-
ing the inhibitory mucoprotein in such a way as to split off a small frag-
ment of the molecule and, by doing so, to deprive the mucoprotein of its
biological activity. Obviously, then, the biological activity of the muco-
proteins towards the influenza virus resides in or is closely associated with
the enzymatically liberated split product, and it seemed of great interest to
find out the composition and structure of this segment of the mucoprotein.
As already mentioned in the earlier review,`5 the split product exhibited
quite unusual features. It had reducing power and showed several reactions
characteristic for carbohydrates, but decomposed with humin formation
when treated with 1.0 N HCl for 30 minutes at 1000 C. It contained nitro-
gen and after treatment with 0.1 N sodium carbonate for 12 minutes at
1000 C. it coupled with the Ehrlich reagent (p-dimethylaminobenzaldehyde
in hydrochloric acid) to give a purple color which spectrophotometrically
was identical with that produced by an authentic specimen of N-acetyl D-
glucosamine. In contrast to N-acetylglucosamine, however, the chromogen
was alkali stable and after treatment with 1.0 N HCI at 1000 for 60 minutes
it failed to give the reaction of Elson and Morgan' shown by N-acetylhexo-
samine after acid de-acetylation. Odin,'S confirming our results, added that
the split product gave the Ehrlich reaction even without pretreatment with
alkali (direct Ehrlich reaction) and drew attention to the identity, in their
general reactions, of the split product and of sialic acid, a reducing acid
of the probable composition C13H23011N or C13H2101oN H20 but of
unknown structure,2 first isolated by Blix' from bovine submaxillary gland
mucin.
A major step towards the elucidation of the structural chemistry of the
enzymatically released compound was taken when 2-carboxy-pyrrole was
isolated'4'7 from the alkali hydrolysate of homogeneous inhibitory muco-
proteins (UM and BSM). The 2-carboxy-pyrrole, like the split product,
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reacts with Ehrlich reagent directly, i.e., without alkali pretreatment and,
being unstable towards mineral acid, loses its chromogenic quality on treat-
ment with acid. Our assumption that 2-carboxy-pyrrole was present as
such in the inhibitory mucoproteins and in the split product was not borne
out by further work. The high value of the molecular extinction coefficient
of 2-carboxy-pyrrole (c = 11700 in phosphate buffer, pH7.0) at a wave-
length (Xma= = 256 m,u), where the aromatic amino acids have a low
extinction coefficient, would have rendered it possible to detect any pre-
formed 2-carboxy-pyrrole in the native mucoprotein and in the split
product. Contrary to expectation neither the undegraded mucoprotein nor
the untreated split product exhibited absorption at 256 mu. However, when
the split product was treated with 0.1 N sodium carbonate for 20 minutes
at 1000, a substance could be extracted with ether from the acidified solu-
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tion which on spectrophotometric and chromatographic analysis proved to be
identical with synthetic 2-carboxy-pyrrole.'6"' These findings suggested the
presence in the mucoprotein and in the split product of a structure readily
converted to 2-carboxy-pyrrole under very mild alkaline conditions. Since
glutamine, glutamic acid, 2-carboxy-5-pyrrolidone, proline, hydroxyproline,
N-acetylglucosamine under mild alkaline conditions did not yield 2-
carboxy-pyrrole, it was postulated'6 that the immediate precursor of 2-
carboxy-pyrrole is the unstable 2-carboxy-4-hydroxypyrroline (I) which
in aqueous solution will undergo reversible ring-opening. The open-chain
product (II) as a /3-oxyketone would be unstable to alkali (or acid) and
reclosure of the ring will result in the formation of 2-carboxy-pyrrole
(III). It was further assumede6"7 that within the framework of the native
mucoprotein, and in the split product, I is prevented from spontaneous
rearrangement to III by substitution at the hydroxyl group (R for H).
Removal by alkali or acid of the substituent R will induce production of III.
Recent developments have both substantiated and qualified this concept.
The coincidence in their general properties of sialic acid from BSM and of
the split product from BSM and UM and our further observation'8 that
along with the enzymatic release of the split product the sialic acid content
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of BSM was reduced by 64 p.c., as estimated spectrophotometrically, sug-
gested close structural relationship, if not identity, of the two compounds
and, by implication, marked sialic acid as the component of BSM giving
rise to the formation of 2-carboxy-pyrrole upon alkali treatment of this
inhibitor. Blix, Lindberg, Odin, and Werner' found sialic acid prepared
from BSM to contain an N-acetyl group, an 0-acetyl group, which is very
easily split off, a primary alcohol group, an ca-hydroxy group, and a total of
five hydroxyl groups. On the basis of these data, its empirical formula
C13H21010N H20, its general properties, and its convertability to 2-
AcO-CH-CH2 HOCNH CH2 HOCH CH2 I I I I
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carboxy-pyrrole we have assigned"8 to sialic acid the provisional structure
IV. Obviously, IV by loss of its two acetyl groups would form VI, i.e., a
delta-substituted II, which in turn would cyclise to the pyrrole VII with
elimination of a tetrose. The susceptibility to acid and alkali of the ester
and amide linkages joining the two acetyl groups to the rest of the sialic
acid molecule would account for the formation of 2-carboxy-pyrrole and
for the direct Ehrlich reaction given by sialic acid and the split product.
An important contribution bearing on the composition of the split
product was made by Klenk and collaborators. In 1951 Klenk' isolated
from gangliosides the methoxy derivative of neuraminic acid, and recently
the same compound was prepared from bovine submaxillary gland mucin
and from the inhibitory urine mucoprotein.' This compound has no reduc-
ing power, is ninhydrin positive, and is stable to alkali; therefore, it does
not give the Ehrlich reaction in the cold after pretreatment with alkali.
However, when heated in mineral acid, the methoxy derivative of neura-
minic acid resembles sialic acid and the split product in the colours formed
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with p-dimethylaminobenzaldehyde and with orcinol and in the intense dis-
coloration on heating even with dilute acid. The compound, on elementary
analysis, was given the formula C11H2109N; it does not contain acetyl
groups. Recently Klenk and Faillard"' isolated N-acetyl neuraminic acid,
C12H21010N, from bovine submaxillary gland mucoprotein. This acid ex-
hibits the same general properties as sialic acid; unlike the methoxy deriva-
tive it has reducing power, is ninhydrin negative, and, most important,
produces 2-carboxy-pyrrole on mild alkali treatment. Finally, it was shown
by Klenk, Faillard, and Lampfrid7 that the enzymatically released split
TABLE 1.
C H N
N-Acetyl neuraminic acid
(a) Calculated for Ci2HnO1toN 42.48 6.23 4.13
(b) Calculated for CuH1909N 42.72 (+0.6%)o* 6.15 (-1.3%) 4.53 (+9.7%)
Found 42.43, 42.17 (0.6%)t 6.27,6.32 (0.8%) 4.07, 4.11, 4.11 (1.7%)
Methoxy neuraminic acid
(a) Calculated for CdlHnO9N 42.44 6.80 4.50
(b) Calculated for C1oH1908N 42.70 (+0.6%)o* 6.76 (-0.6%) 4.98 (+10.7%)
Found ~~~~~42.26,42.48~( 6.8,6.7/ 4.31,4.43~ 9% F42.51,42.65}(079%)t 17.03,7.105(38%) 4.51,4.73}
* Denotes increase (+) or decrease (-) of b with respect to a.
tDenotes difference between extreme values.
product from UM on purification is identical with N-acetyl neuraminic
acid. In our opinion the relationship between sialic acid, N-acetyl neura-
minic acid, and 2-carboxy-pyrrole on the one hand and between sialic acid
and the methoxy derivative of neuraminic acid on the other hand is best
expressed by the structures IV-IX.
This scheme requires a comment. Whereas Klenk and associates"'"2"
consider N-acetyl neuraminic acid and the methoxy derivative of neura-
minic acid to have the formulae C12H21010N and C11H2109N, respectively,
we believe that their analytical data are not at variance with the formulae
C1LH1909N and CloH1908N, respectively, as assigned to the two com-
pounds in V and IX. In Table 1 the calculated values for the elements
according to the composition assigned to them by Klenk and assigned to
them in V and IX are compared with the data published by Klenk and
associates.R'a 28b, '- As may be seen from the figures for methoxy neuraminic
acid, the differences between the C, H, and N values for the two assumed
formulae are not larger than the differences between two individual analyses
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of these elements, i.e., they fall within the experimental error of the method.
The same holds for the C and H values of N-acetyl neuraminic acid. The
analytical figures for N of N-acetyl neuraminic acid, taken at their face
value, seem to fit Klenk's formula better than V. An examination, however,
of the experimental details provided by Klenk shows that due to the very
small amount of material (2.04-2.40 mg.) available for the Kjeldahl pro-
cedure a difference of 0.04 ml. (one drop) of N/100 HCl which is within
the error of the method introduces an experiment error of ± 7 p.c. under
these conditions. We conclude from the above analysis of Klenk's figures
that they do not allow a differentiation between the formulae as proposed
by him and as suggested in V and IX, respectively; they are consistent
with our interpretation.
From Blix's datae it seems very probable that sialic acid from BSM is
diacetyl neuraminic acid (IV) and it may be useful to restrict this name to
the diacetyl derivative* of neuraminic acid. The details of Blix's latest pro-
cedure have not yet been published; there remains the uncertainty that
different preparations of bovine sialic acid though exhibiting the same
X-ray diagrams are not consistent enough in their elementary analysis to
establish definitely the composition of BSM sialic acid.2 Should the presence
of an 0-acetyl group in this compound be confirmed, then N-acetyl neura-
minic acid (V) as obtained from BSM by Klenkla is an artifact derived
from sialic acid (IV) by loss of the 0-acetyl group during purification. The
same may be true for the split product released by the viral enzyme from
UM.7 Blix and associates2 have prepared from ovomucin "ovine sialic acid"
of the composition C11H19O9N containing an N-acetyl group only and
almost certainly identical with N-acetyl neuraminic acid. "Porcine sialic
acid" has no acetyl group but instead an N-glycolyl group.2
It would be most desirable to establish firmly whether or not the N-
substituted neuraminic acids of bovine and porcine submaxillary gland
mucins, of UM, and of ovomucin have an 0-acetyl group in addition to the
N-acyl group, because this question has wider implications. N-Acetyl
neuraminic acid in solution is unstable; it decomposes under discoloration
within days even at 10 C.'2 If, as Klenkla,27 assumes, N-acetyl neuraminic
acid is present as such in BSM and UM, it must be stabilized by its linkage
to the adjacent unit within the mucoprotein molecule; for an 1 p.c. disper-
sion of ovomucin containing 0.04 p.c. lysozyme (final concentration) may
be kept at 0° C. for months without losing its biological activity or chang-
ing its snow-white colour. Stabilization of V other than by 0-acetyl (IV)
*To Blix' goes the credit of having first isolated this compound from BSM. It seems,
however, inadvisable to denote with the same name compounds of different chemical
composition though they may be closely related to or derived from sialic acid.
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would result from the engagement of its keto group in a glycosidic linkage
in analogy to IX. An ordinary 0-glycosidic linkage may be excluded from
the facts that both the native mucoprotein and N-acetyl neuraminic acid
form 2-carboxy-pyrrole on alkali treatment,"" a whereas the acetal or 0-
glycoside methoxy neuraminic acid does not (1ON NaOH, 2 hr., 1000
C.).
O An N-glycosidic linkage mediated by the amino group of an adjacent
amino acid or amino sugar would stabilize V efficiently and would explain
the release of sialic acid from BSM by the simple expedient of heating its
solution at neutrality to 110-115° C.;' for many synthetic N-glycosides are
known to hydrolyse under very mild conditions, some of them even at pH
7.o.'
" ' Such a linkage would in no way hinder theformation of 2-carboxy-
pyrrole from mucoproteins on alkali treatment; moreover, its cleavage by
the action of RDE, involving the loss of a -COO group and the gain of a
-NH3' group, would account for the considerable reduction in electro-
phoretic mobility of BSM and UM after such treatment.7 In this context
it is of interest that Inouye and Onodera and Dische and Jacubeit8 have
isolated from glycoproteins compounds consisting of a mono- or disac-
charide in N-glycosidic linkage with the amino group of an amino acid.
Though the scheme presented seemed to be consistent with the data
provided by the Swedish, German, and Australian laboratories, it was
desirable to obtain further experimental evidence for its validity. The struc-
ture assigned to neuraminic acid (VI) may be visualized as an aldol type
of condensation product of 2-amino-2-deoxyhexose with pyruvic acid, a
type of linkage rendering recovery of the amino sugar by acid treatment
impracticable and yet allowing the masked hexosamine to play its full part
in the chromogen formation in the direct and indirect Ehrlich reactions, as
was indeed observed. ""' The tendency of pyruvic acid to condense with
aldehydes has long been known; thus the reaction
-H20
C6H5*CHO +CH3*CO COOH-> C6H5*CH: CH*CO*COOH
proceeds at 50 C. when carried out in the presence of NaOH (Erlen-
meyer10). On this reasoning it was expected that under alkaline conditions
pyruvic acid would condense with hexosamine to form VI, a reaction
accompanied by closure of the ring, loss of 2 moles water, rearrangement
of the double bonds and elimination of a tetrose (VI-*VII). This was
verified experimentally.'8 When pyruvic acid (0.1 N solution) was allowed
to react with D-glucosamine in the molecular ratio 1: 3 at 1000 for several
hours under controlled conditions of alkalinity, 2-carboxy-pyrrole could be
extracted from the reaction mixture in a yield of about 20 p.c.; the com-
pound was obtained in crystalline form and identified so far by its melting
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point, mixed melting point, U-V absorption spectrum, and chromatogra-
phic behaviour." D-Galactosamine was found to be as suitable a partner in
the condensation reaction as D-glucosamine, both yielding 2-carboxy-
pyrrole.' The condensation of hexosamine and pyruvic acid to the pyrrole
COOH
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compound may be regarded as an analogue to the Knorr type condensation
of 2 mols of 8-amino-laevulinic acid to the pyrrole derivative porphobilino-
gen (X-XIII), demonstrated by Shemin and RussellM and by Neuberger
and Scott."' In both cases the same reactive groups are involved in the con-
densation (XIV and XV). The main difference is that in 8-aminolaevulinic
acid R' = H and on condensation 2 mols H20 are formed concomitant
with pyrrole synthesis; in hexosamine R'= -CHOH
- (CHOH)2 CH20H
and upon condensation with pyruvic acid fragmentation of the hexosamine
structure by reverse aldolization takes place resulting in the production of
2-carboxy-pyrrole, 2 mols H20 and a tetrose; the latter is further degraded
under the prevailing alkaline conditions.
Neuraminic acid (VI), being an a-keto acid, is readily decarboxylated
by mineral acid to form the next lower aldehyde. This aldehyde may be
regarded as a substituted 2-deoxyhexose and it is due to this structural
feature that sialic acid gives a very similar colour reaction (violet colour
with maximum absorption at 530 m,u) with Dische's diphenylamine reagent
as do 2-deoxyhexoses22a and glycals (red colour with maximum absorption
515 mpu). Quite probably the same structural feature of 2-deoxy-sugar is
responsible for the decomposition with discoloration of sialic acid and N-
acetyl neuraminic acid on heating with dilute mineral acid, 2-deoxy-
glucose,TM and 2-deoxy-galactose* exhibiting the same property. It is thus
evident that all properties described for sialic acid, N-acetyl neuraminic
acid and the split product are consistent with structures IV and V; the
exact position of the 0-acetyl group in IV remains to be determined.
From the previous discussion it is obvious that the direct Ehrlich
reaction as given by BSM, UM and ovomucin is due to the presence in
them of N-acetyl neuraminic acid or of diacetyl neuraminic acid (sialic
acid). There is no indication that these or similar mucoproteins contain
any other component but neuraminic acid reacting after rearrangement
directly, i.e. without alkali pretreatment, with Ehrlich reagent to give a
stable colour with absorption maxium at 565 m,u under standard conditions
as defined by Werner and Odin.'m This statement is based on two series of
observations: (1) The following substances failed to give a positive direct
Ehrlich reaction as defined above: Hyaluronic acid, chondroitin sulfuric
acid, heparin, carbohydrate-free proteins, tryptophan.7 2. The determina-
tion of "sialic acid" in a variety of mucoproteins by independent methods
(diphenylamine reaction, tryptophan-perchloric acid reaction) gave values
varying by not more than 10 p.c. from those obtained by the method based
on the direct Ehrlich reaction.'m It seems therefore legitimate to apply the
* Dr. E. L. Hess, Chicago, personal communication.
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direct Ehrlich reaction as an approximate measure of the neuraminic acid
content of a mucoprotein though a check by an independent method may be
desirable. The value obtained is approximate only since it is customary to
take Blix's sialic acid preparation from BSM as standard and we cannot
be absolutely sure that the various neuraminic acid derivatives (N-acetyl
neuraminic acid, N-glycolyl neuraminic acid, and possibly others) give
molecule for molecule under standard conditions the same colour intensity
as sialic acid. With this reservation Table 2 summarizes the amounts in
some mucoproteins of direct Ehrlich-reacting neuraminic acid derivatives
expressed as sialic acid.
TABLE 2. "SIALIc ACID" CONTENT* OF VARIOUS MUCOPROTEINS
Sialic acid
Mucoprotein p.c. References
Bovine submax. gland mucoprotein 16.8 37
Bovine serum albumin 1.7t 21
Acid glycoprotein of human plasma 10.1 37
Seromucoid (Rimington) 8.5 37
a2-Globulin (Cohn's fraction IV-6-2) 5.7 37
Human urine inhibitory mucoprotein 9.2 32
Human meconium 8.7t 21
Blood-group active mucoids from
ovarian cyst fluids 1.1-8.2 11
Thyroglobulin 2.7t 21
Ovomucin 5.8 37
Ovomucoid 2.0t 21
* See text.
t Standard = homogeneous bovine submax. gland mucoprotein assuming a content
of 16.8 p.c. sialic acid.
In contrast to the direct Ehrlich reaction a positive Ehrlich reaction of a
mucoprotein after mild alkali treatment (0.05 N Na2CO3, 15 minutes,
1000 C.), first observed by Morgan and King,"' does not lend itself to a
ready interpretation. This indirect Ehrlich reaction is a complex reaction
involving neuraminic acid, N-acetylglucosamine, N-acetylgalactosamine,
N-glycosyl amino-acids and possibly other substances. The mechanism of
this reaction is not fully understood due to the variety of reactions sugars
are undergoing under the impact of alkali (enolization, condensation, frag-
mentation, recombination, disproportionation, etc.'). Several chromogens
are formed in the reaction. Stanley," participating in our earlier work, has
separated by dialysis material liberated by 0.05 N Na2CO3 (20 minutes,
100° C.) from ovomucin and demonstrated chromatographically the
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presence of four different substances reacting after this treatment with
Ehrlich reagent; in addition to these chromogens, unchanged free N-
acetylglucosamine was found to be present. We have submitted BSM to the
same mild alkali treatment for 15 minutes and detected in the concentrated
dialysate three different chromogens by chromatography (solvent: n-
butanol / pyridine / water; RF values 0.15, 0.86, 0.90) reacting with Ehr-
lich reagent. After acid hydrolysis of the dialysate an amino compound was
isolated by adsorption to and elution from Dowex 50 according to Boas'
and identified as galactosamine, the predominant amino sugar of BSM," by
oxidation with ninhydrin to lyxose. In this way 4 p.c. of the hexosamine
known to be present in BSM was recovered unchanged. In view of these
findings it seems rather arbitrary to compare the colour produced in the
Ehrlich reaction of a mucoprotein after mild alkali treatment with an N-
acetylglucosamine standard; until more is known about the chemistry and
origin of the various chromogens formed and their colour intensity in the
Ehrlich reaction compared with that given by N-acetylglucosamine, little
information is conveyed by determining quantitatively the "N-acetylhexo-
samine colour"' of a mucoprotein.
From the evidence discussed in this paper it would appear that the bio-
logical activity of a group of mucoproteins, as displayed by their inhibitory
effect upon haemagglutination by heated influenza virus, resides in the
N-acetyl neuraminic acid component of these conjugated proteins; this has
been established for BSM, UM, and ovomucin. Whether or not one or
more of them contain in addition an 0-acetyl group has yet to be proven;
for BSM the presence of neuraminic acid in its diacetyl form seems ex-
tremely probable. Neuraminic acid has been shown with a high degree of
probability to be an aldol type of condensation product of hexosamine with
pyruvic acid. The release of N-acetyl neuraminic acid, catalysed by the
influenza virus enzyme and by a soluble enzyme from vibrio cholerae, irre-
versibly inactivates the mucoprotein. N-Acetyl neuraminic acid represents,
therefore, the functional group of the virus haemagglutinin inhibitory muco-
proteins, either on its own or as the specific component of a terminal unit.
Klenk, Faillard, and Lempfrid-7 have confirmed our previous observa-
tione that paper chromatography of the split product reveals the presence of
several amino acids. However, the authors apparently have not yet tested
the controls for these ninhydrin reacting substances; the matter is still
under investigation. In our experience BSM, UM, and ovomucin release,
for some unknown reason, continuously minute amounts of amino acids;
the chromatographic analysis of the split product has, therefore, carefully
to be checked against the chromatograms obtained from appropriate con-
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trols. If this is done, possibly one or two amino acids remain, and their
release may be associated with the virus-mucoprotein interaction."2
It is to be hoped that continued research will consolidate our knowledge
about the chemistry of the various neuraminic acid derivatives present in
mucoproteins and lead to the chemical and enzymatic synthesis of N-acetyl
neuraminic acid. From such studies there might eventually emerge a clearer
concept of the function of neuraminic acid which seems to represent a
unique example of a fusion product between a static and a dynamic sugar
derivative.
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